Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,929 | 8,249 | 7,360 | 4,987 | 5,599 |
| Receivables | 64 | 42 | 58 | 33 | 63 |
| TOTAL | $17,420 | $8,891 | $8,199 | $5,845 | $6,202 |
| Non-Current Assets | |||||
| PPE Net | 3 | 3 | 1 | 2 | 2 |
| Intangibles | 473 | 484 | 494 | 462 | 471 |
| TOTAL | $476 | $487 | $495 | $463 | $473 |
| Total Assets | $17,896 | $9,378 | $8,694 | $6,308 | $6,675 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 353 | 617 | 626 | 756 | 172 |
| Accrued Expenses | 451 | 190 | 204 | 164 | 420 |
| TOTAL | $1,078 | $1,085 | $1,011 | $1,159 | $755 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,078 | $1,085 | $1,011 | $1,159 | $755 |
| Shareholders' Equity | |||||
| Common Shares | 42,403 | 31,224 | 27,940 | 24,011 | 22,947 |
| Retained earnings | -35,049 | -30,902 | -27,302 | -24,569 | -22,322 |
| Other shareholders' equity | 9,464 | 7,971 | 7,045 | 5,708 | 5,295 |
| TOTAL | $16,818 | $8,293 | $7,683 | $5,150 | $5,920 |
| Total Liabilities And Equity | $17,896 | $9,378 | $8,694 | $6,308 | $6,675 |